David Nour
David Nour has extensive commercial background, having worked in private wealth management and professional investment for over 25 years with CBA & Bluestone Group.
David Nour has extensive commercial background, having worked in private wealth management and professional investment for over 25 years with CBA & Bluestone Group.
| Rank | Company | 1 Yr | 5 Yr |
|---|---|---|---|
| 1343rd | Paragon Care | -24.55% | 13.02% |
| 1344th | BPH Energy | -24.59% | -27.46% |
| 1345th | Global Uranium and Enrichment | -24.73% | -19.13% |
| 1346th | Australian Clinical Labs | -24.82% | 0% |
| 1347th | Legend Mining | -24.94% | -41.36% |
|
NEW ROLE: Executive Director, Global Uranium and Enrichment | 13 May 2021 |
| Position | Company | Year | Company's current rank |
|---|---|---|---|
Non-Executive Director
|
2019 - 2021 | ||
Executive Director
|
2021 - 2021 |
| Company | Date | Transaction type | Number of shares | Price per share | Transaction value | Nature of change |
|---|---|---|---|---|---|---|
| 2021-11-30 | Other | 3,000,000 | $0.00 | Other | ||
| 2021-11-30 | Other | 3,000,000 | $0.00 | Other | ||
| 2021-10-29 | Bought | 3,000,000 | $0.00 | Other | ||
| 2021-10-29 | Other | 3,000,000 | $0.00 | Other | ||
| 2021-09-01 | Bought | 21,082 | $0.20 | $4,216 | On-market trade |